Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

LEEDS, United Kingdom--(BUSINESS WIRE)-- #cancerdiagnostics--A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision cancer diagnostics solutions. NHS is the UK's National Health Service. The technology, known as TANGO, is a world-first, laboratory quality tool developed by researchers at Leeds Teaching Hospitals' National Pathology Imaging Co-operative (